Abstract

Population ageing has led to an increase in the prevalence and complexity of heart disease. It is common for these patients to have a high comorbidity load, and this is an important prognostic factor. Assessment of comorbidity has become a concern and therefore methods such as the Charlson Comorbidity Index have been developed. The main comorbidities affecting these patients’ prognosis include frailty, diabetes mellitus, chronic kidney disease, chronic obstructive pulmonary disease, and inflammatory disease. These patients’ poorer prognosis appears to be related to diagnostic delay due to atypical clinical symptoms, baseline laboratory and electrocardiographic abnormalities, and less use of therapies with proven efficacy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.